Allergan Aesthetics Receives Positive CHMP Opinion for TrenibotulinumtoxinE for Glabellar Lines
The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.
Search fresh public links, source activity, and post angles for Allergan Aesthetics.
Fresh curated links around Allergan Aesthetics are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.
The Austin site expands US training offerings with hands-on education in aesthetic procedures and practice development.
Agency requests additional manufacturing information and does not cite safety or efficacy concerns or require new clinical studies.
Filler cleared for infraorbital hollow and horizontal forehead lines in Europe.
Granbury-based nurse injector Brittney Martin, BSN, RN, earns national recognition through peer nominations and patient votes, while the practice becomes one of the first in North...
The analysis shows that the top 15 brands capture approximately 62% of the total AI citation share as patients increasingly use platforms like ChatGPT and Google AI Overviews to re...
With the addition of Aesthetic Artistry Laser Center, Aviva Aesthetics further strengthens its presence across key markets while preserving practice ownership and autonomy. CHICAGO...
As GLP-1 medications drive significant weight loss for more patients, aesthetic providers are seeing a rise in facial hollowing, skin laxity, and other changes associated with GLP-...
Ipsen has shared phase 2 data on its long-acting neurotoxin, reporting an increase in the proportion of people with significant improvements in frown lines 24 weeks after treatment...
Agreement for CellREDM highlights growing interest in regenerative injectables used alongside fillers.
The acquisition aims to create a new patient acquisition channel by connecting aesthetic practices with corporate skin health and wellness programs.
Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placebo At Week 24, 60.8% of patients treated with corabotase...
Botox manufacturer Allergan has asked a Tennessee federal judge to sanction Revance Therapeutics, claiming its attorneys made misrepresentations to run out the clock on discovery a...
The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.
Practice Transitions Group served as the exclusive sell-side advisor on the Preva Aesthetics transaction, with Lauren Wheeler as lead advisor. AUSTIN, Texas, May 19, 2026 /PRNewswi...
The global medical aesthetics market is currently expanding at a record pace, with data suggesting the injectables sector will surpass $15 billion by 2030. The surge in popularity...
BusinessRate recognition reflects consistently positive patient feedback and trusted facial plastic surgery care in Irvine and throughout Orange County.
Corabotase is the first investigational molecule in a newly designated class of recombinant neuroinhibitors, RNITM, as recognized by the WHO and USAN Phase II data in glabell...
The organizations highlighted new leadership appointments, membership growth, education initiatives, and patient safety efforts during The Aesthetic MEET 2026 in Boston.
Perfect Corp. (NYSE: PERF), the leading AI and AR beauty and fashion technology provider, today announced the release of its latest trend report, The Modern Aesthetics Consumer: E...
Emily Hu, MD, shares insights from a recent report on HA injectables, examining patient perceptions, persistent myths, and clinical realities.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.